XML 45 R39.htm IDEA: XBRL DOCUMENT
v3.25.3

Stock-Based Compensation (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract] |
Schedule of Assumptions Used to Determine Grant-date Fair Value of Stock Options Granted | The following table presents, on a weighted-average basis, the assumptions used in the Black-Scholes option pricing model to determine the grant-date fair value of stock options granted:
|  | Nine Months Ended September 30, |
|  | 2025 |  |  | 2024 |
Fair value of common stock |  | $ | 14.38 |  |  | $ | 10.95 |
Risk-free interest rate |  |  | 4.25 | % |  |  | 4.08 | %
Expected term (in years) |  |  | 5.97 |  |  |  | 6.02 |
Expected volatility |  |  | 100.01 | % |  |  | 86.57 | %
Expected dividend yield |  |  | 0 | % |  |  | 0 | %
Summary of Stock Options Activity | The following table summarizes stock option activity for the nine months ended September 30, 2025:
|  |  |  |  |  |  |  | Weighted- |  |  |  |
|  |  |  |  | Weighted- Average |  |  | Average Remaining |  |  | Aggregate |
|  | Number of Options |  |  | Exercise Price |  |  | Contractual Term |  |  | Intrinsic Value |
|  |  |  |  |  |  |  | (in years) |  |  | (in thousands) |
Outstanding at December 31, 2024 |  |  | 5,667,555 |  |  | $ | 6.98 |  |  |  | 7.6 |  |  | $ | 22,929 |
Granted |  |  | 1,731,539 |  |  | $ | 17.85 |  |  |  |  |  |  |
Exercised |  |  | (462,107 | ) |  | $ | 6.04 |  |  |  |  |  |  |
Forfeited or cancelled |  |  | (156,340 | ) |  | $ | 9.95 |  |  |  |  |  |  |
Expired |  |  | (15,396 | ) |  | $ | 7.09 |  |  |  |  |  |  |
Outstanding at September 30, 2025 |  |  | 6,765,251 |  |  | $ | 9.76 |  |  |  | 7.5 |  |  | $ | 68,553 |
Vested and expected to vest at September 30, 2025 |  |  | 6,765,251 |  |  | $ | 9.76 |  |  |  | 7.5 |  |  | $ | 68,553 |
Options exercisable at September 30, 2025 |  |  | 3,536,423 |  |  | $ | 7.74 |  |  |  | 6.6 |  |  | $ | 42,854 |
Summary of Non-Vested Stock Options | The following table summarizes the non-vested stock options that were outstanding as of September 30, 2025 and December 31, 2024:
|  |  |  |  | Weighted- Average |
|  | Number of Options |  |  | Exercise Price |
Non-vested options, September 30, 2025 |  |  | 3,228,828 |  |  | $ | 11.97 |
Non-vested options, December 31, 2024 |  |  | 2,797,887 |  |  | $ | 6.86 |
Summary of RSU Activity | The following table summarizes RSU activity under the Company's incentive plans for the nine months ended September 30, 2025:
|  |  |  |  | Weighted- Average |
|  | Number of Shares |  |  | Grant Date Fair Value |
RSUs outstanding, December 31, 2024 |  |  | — |  |  | $ | — |
Granted |  |  | 1,056,299 |  |  | $ | 14.69 |
Vested |  |  | (190,222 | ) |  | $ | 14.59 |
Cancelled |  |  | (41,306 | ) |  | $ | 14.52 |
RSUs outstanding, September 30, 2025 |  |  | 824,771 |  |  | $ | 14.72 |
Schedule of Stock-Based Compensation Expense by Type and Financial Statement Line | Stock-based compensation expense by type and financial statement line is included in the Company’s statements of operations and comprehensive loss as follows:
|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
|  | (in thousands) |  |  | (in thousands) |
Options |  | $ | 3,116 |  |  | $ | 1,976 |  |  | $ | 8,721 |  |  | $ | 4,832 |
RSUs |  |  | 1,362 |  |  |  | — |  |  |  | 3,360 |  |  |  | — |
Total stock-based compensation expense |  | $ | 4,478 |  |  | $ | 1,976 |  |  | $ | 12,081 |  |  | $ | 4,832 |
|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
|  | (in thousands) |  |  | (in thousands) |
Cost of sales |  | $ | 140 |  |  | $ | 69 |  |  | $ | 399 |  |  | $ | 201 |
Research and development |  |  | 893 |  |  |  | 294 |  |  |  | 2,319 |  |  |  | 844 |
Sales and marketing |  |  | 1,273 |  |  |  | 472 |  |  |  | 3,388 |  |  |  | 1,150 |
General and administrative |  |  | 2,172 |  |  |  | 1,141 |  |  |  | 5,975 |  |  |  | 2,637 |
Total stock-based compensation expense |  | $ | 4,478 |  |  | $ | 1,976 |  |  | $ | 12,081 |  |  | $ | 4,832 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration